SQZ Biotechnologies Dirección
Dirección controles de criterios 2/4
El CEO de SQZ Biotechnologies' es Howard Bernstein , nombrado en Nov 2022, tiene una permanencia de 1.58 años. compensación anual total es $1.62M, compuesta por 24.6% salario y 75.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.2% de las acciones de la empresa, por valor de $2.68K. La antigüedad media del equipo directivo y de la junta directiva es de 2.5 años y 3.7 años, respectivamente.
Información clave
Howard Bernstein
Chief Executive Officer (CEO)
US$1.6m
Compensación total
| Porcentaje del salario del CEO | 24.6% |
| Permanencia del CEO | 1.6yrs |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | 2.5yrs |
| Promedio de permanencia en la Junta Directiva | 3.7yrs |
Actualizaciones recientes de la dirección
Recent updates
SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%
Jun 26
We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully
Jan 05SQZ Biotechnologies GAAP EPS of -$0.77 beats by $0.06, revenue of $3.5M misses by $0.76M
Nov 09SQZ Biotech spikes as H.C. Wainwright initiates with Buy citing platform technology
Oct 20Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?
Aug 20SQZ Biotechnologies GAAP EPS of -$0.78 misses by $0.01, revenue of $3.22M misses by $0.97M
Aug 04SQZ Biotechnologies names business chief as CFO
Jul 11Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook
May 17Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation
May 02Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation
Jan 11Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?
Jul 30Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)
May 16Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts
Mar 25SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 20We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth
Feb 01
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$72m |
| Jun 30 2023 | n/a | n/a | -US$71m |
| Mar 31 2023 | n/a | n/a | -US$76m |
| Dec 31 2022 | US$2m | US$400k | -US$79m |
| Sep 30 2022 | n/a | n/a | -US$78m |
| Jun 30 2022 | n/a | n/a | -US$78m |
| Mar 31 2022 | n/a | n/a | -US$74m |
| Dec 31 2021 | US$1m | US$391k | -US$69m |
| Sep 30 2021 | n/a | n/a | -US$75m |
| Jun 30 2021 | n/a | n/a | -US$64m |
| Mar 31 2021 | n/a | n/a | -US$55m |
| Dec 31 2020 | US$750k | US$357k | -US$51m |
Compensación vs. Mercado: La compensación total de Howard($USD1.62M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD673.68K).
Compensación vs. Ingresos: La compensación de Howard ha aumentado mientras la empresa no es rentable.
CEO
Howard Bernstein (67 yo)
1.6yrs
Permanencia
US$1,624,513
Compensación
Dr. Howard Bernstein, M.D., Ph D., had been Chief Scientific Officer of SQZ Biotechnologies Company since June 2015 until October 31, 2022. Dr. Bernstein is Director of SQZ Biotechnologies Company since Oc...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Interim CEO & Director | 1.6yrs | US$1.62m | 0.20% $ 2.7k | |
| General Counsel & Secretary | 4.8yrs | US$944.03k | 0.0066% $ 87.2 | |
| Chief Medical Officer | 2yrs | US$944.27k | 0% $ 0 | |
| Co-Founder & Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Chief Accounting Officer | 2.6yrs | sin datos | sin datos | |
| Chief People Officer | 4.1yrs | sin datos | sin datos | |
| Senior Vice President of CMC & QUALITY | 2.4yrs | sin datos | sin datos |
2.5yrs
Permanencia media
62yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de SQZB se considera experimentado (2.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Interim CEO & Director | 1.7yrs | US$1.62m | 0.20% $ 2.7k | |
| Co-Founder & Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Director | no data | US$104.40k | 0.74% $ 9.8k | |
| Independent Director | 2.9yrs | US$96.62k | 0% $ 0 | |
| Independent Director | 11.3yrs | US$89.40k | 1.15% $ 15.3k | |
| Independent Chairman | 2.9yrs | US$94.40k | 0% $ 0 | |
| Independent Director | 6.1yrs | US$86.90k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 5.8yrs | US$94.40k | 0% $ 0 | |
| Independent Director | 3.7yrs | US$94.40k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
3.7yrs
Permanencia media
62yo
Promedio de edad
Junta con experiencia: La junta directiva de SQZB se considera experimentada (3.7 años de antigüedad promedio).